2 months JPMorgan Chase & Co. Increases Teva Pharmaceutical Industries (NYSE:TEVA) Price Target to $18.00 MarketBeat
JPMorgan Chase & Co. lifted their target price on Teva Pharmaceutical Industries from $16.00 to $18.00 and gave the company a “neutral” rating in a research note on Monday.
JPMorgan (JPM) · NYSE · Science
X